- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2014
- Public Summary Document (PSD) March 2014 PBAC Meeting - PDF
Trastuzumab emtansine – March 2014
TRASTUZUMAB EMTANSINE, injections, 100 mg vial and 160 mg vial, Kadcyla®, Roche Products Pty Ltd
Last updated
8 November 2023